神经内镜微创手术治疗幕上高血压脑出血效果研究

目的 探讨神经内镜微创手术对幕上高血压脑出血患者血肿清除效果及神经功能的影响。方法 选择2018年1月—2019年1月就诊于某医院的84例幕上高血压脑出血患者,按随机数字表法分为两组,各42例。研究组行神经内镜微创手术,对照组行小骨窗开颅显微手术。对比两组手术情况、术后日常生活能力、神经功能缺损情况和并发症发生情况。结果 研究组手术情况优于对照组,差异有统计学意义(P<0.05);研究组日常生活能力评分量表(ADL)评分为(65.39±5.58)分,高于对照组的(46.65±4.42)分,神经功能缺损评分(CSS)评分为(29.38±2.07)分,低于对照组的(34.22±2.17)分,(P<0.05);研究组术后并发症发生率为7.14%,低于对照组的23.81%,(χ2=4.459,P=0.035)。结论 对幕上高血压脑出血患者行神经内镜微创手术治疗,血肿清除率高,可减少术中失血量,缩短手术操作和ICU入住时间,促进神经功能恢复,提高日常生活能力,安全性较高。

Therapeutic effect of neuroendoscopic minimally invasive surgery in treatment of hypertensive supratentorial cerebral hemorrhage

Objective To explore the therapeutic effect of neuroendoscopic minimally invasive surgery on the removal hematoma and the neurological function of hypertensive supratentorial cerebral hemorrhage. Methods From January 2018 to January 2019, 84 cases of hypertensive supratentorial cerebral hemorrhage were divided into a trial group and a control group according to the random number table method. In the trial group, the neuroendoscopic minimally invasive operation was performed, and the control group was treated with small-bone-window craniotomy. The operative condition, the ability of daily life after the operation, the defect of the neurological function, and the occurrence of the complications were investigated and compared between two groups. Results The operation condition of the trial group was superior to that of the control group, the difference was statistically significant (P<0.05). The score of the Normal Life-ability Score (ADL) was (65.39±5.58) points of the trial group, which was higher than that of the control group , and the score of the Neurological Deficit Score (CSS) was (29.38-2.07) points, which was lower than that of the control group , and the difference was statistically significant (P<0.05). The incidence of postoperative complications in the trial group was 7.14%, which was lower than that in the control group (23.81%, χ2=4.459, P=0.035). Conclusion The therapeutic of neuroendoscopic minimally invasive surgery in the treatment of hypertensive supratentorial cerebral hemorrhage is obvious, and the clearance of the hematoma is high. It is safe and it can reduce the amount of blood lost during the operation, shorten the operation time and ICU time, promote the recovery of nerve function, and improve the ability of daily life of the patients.